Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment

Traci C. Green, Jeffrey Bratberg, Deborah S. Finnell

Research output: Contribution to journalEditorialpeer-review

Abstract

We highlight the critical roles that pharmacists have related to sustaining and advancing the changes being made in the face of the current COVID-19 pandemic to ensure that patients have more seamless and less complex access to treatment. Discussed herein is how the current COVID-19 pandemic is impacting persons with substance use disorders, barriers that persist, and the opportunities that arise as regulations around treatments for this population are eased.

Original languageEnglish (US)
Pages (from-to)147-149
Number of pages3
JournalSubstance Abuse
Volume41
Issue number2
DOIs
StatePublished - Apr 2 2020

Keywords

  • Pandemic
  • buprenorphine
  • methadone
  • opioid use disorder
  • pharmacists
  • policy
  • regulations

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment'. Together they form a unique fingerprint.

Cite this